Liliya R. Selimzyanova

Liliya R. Selimzyanova

Auto-generated profile, based on publicly available information

Liliya R. Selimzyanova

Pediatrics and Child Health Research Institute in Petrovsky National Research Centre of Surgery; Sechenov First Moscow State Medical University; Pirogov Russian National Research Medical University

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2022 in PULMONOLOGIYA
Verified
Journal Article
Closed access
PDF file
EKElena Kondatyeva
Elena Kondatyeva
SASergey Avdeev
Sergey Avdeev
YMYu. L. Mizernitskiy
Yu. L. Mizernitskiy
Aleksander V. PolyakovAleksander V. Polyakov
Aleksander V. Polyakov
MCMarina Chernukha
Marina Chernukha
ЮМЮ. Л. Мизерницкий
Ю. Л. Мизерницкий
Primary ciliary dyskinesia (PCD) is a rare hereditary disease from the group of ciliopathies, which is based on a defect in the cilia ultrastructure of the respiratory epithelium and similar structures (sperm flagella, villi of the fallopian tubes, ventricular ependyma, etc.), leading to motor function impairment. The prevalence of the disease varies significantly around the world and is not known reliably in the Russian Federation.The aim of the review was to analyze literature data on modern approaches to the diagnosis and treatment of PCD.Methodology. The data of 90 articles and the opinions of experts providing care to patients with PCD were used.Results. The classic manifestations of PCD depend on age. The leading manifestations of the disease in patients with PCD are recurrent inflammatory diseases of the upper and lower respiratory tract (bronchitis, pneumonia), with the formation of bronchiectasis, damage to the ENT organs (chronic rhinitis, rhinosinusitis, nasal polyposis, repeated otitis media, progressive hearing loss). Currently, there is no single method which could serve as a “gold” standard for diagnosing PCD. The diagnosis of PCD is based on the characteristic clinical picture in combination with the results of special tests (nitric oxide in exhaled air, DNA diagnostics, high-speed video microscopy, transmission electron microscopy). The genetic diagnostics has not been developed sufficiently in the global practice yet and is unavailable in our country. The approach to the treatment of a patient with PCD should be multidisciplinary due to multiple organ lesions. According to the European consensus, the goal of PCD therapy is to restore or maintain normal lung function. There have been no randomized trials of treatment for PCD, and therefore all treatment recommendations are based on very low-level evidence or extrapolated from cystic fibrosis guidelines. Recommendations on mucolytic, antibacterial and anti-inflammatory therapy of PCD are given with consideration for the international and domestic experience.Conclusion. The development of a new version of clinical guidelines containing up-to-date relevant information will improve the diagnosis and treatment of PCD in the Russian Federation.

1 January 2016 in Current Pediatrics
Verified
Journal Article
Open access
PDF file
LNLeyla S. Namazova-Baranova
Leyla S. Namazova-Baranova
AБArray А. Баранов
Array А. Баранов
AКArray А. Кубанова
Array А. Кубанова
NIN. I. Ilina
N. I. Ilina
OKO. M. Kurbacheva
O. M. Kurbacheva
AСArray Р. Селимзянова
Array Р. Селимзянова
Атопический дерматит у детей: современные клинические рекомендации по диагностике и терапии

20 August 2020 in Pediatric pharmacology
Verified
Journal Article
Open access
PDF file
YAYurii S. Alexandrovich
Yurii S. Alexandrovich
EAEkaterina I. Alekseeva
Ekaterina I. Alekseeva
MBMaya D. Bakradze
Maya D. Bakradze
ABAlexander A. Baranov
Alexander A. Baranov
TBTatiana T. Batysheva
Tatiana T. Batysheva
АЯА. В. Яковлев
А. В. Яковлев
The Ministry of Health of the Russian Federation jointly with professional association and experts in the field of pediatrics, infectious diseases and resuscitation has revised guidelines “Clinical Features and Management of the Disease Caused by New Coronaviral Infection (COVID-19) in Children” in order to provide the child population with effective medical care during the pandemic of the new coronaviral infection. The practical experience of specialists from various countries was considered during the development of this document. Special attention should be given to the evidence base of the presented data, as well as to the efficiency and safety issues of medications used in treatment of coronaviral infection and its complications. The authors highlight the problems of prevention, diagnostics and management of pathological conditions caused by COVID-19 in the article according to the presented guidelines. Patient’s management is presented depending on the age and severity of the disease itself. The therapy is considered with regard to etiological, pathogenetic and symptom focus.

6 July 2018 in Pediatric pharmacology
Verified
Journal Article
Open access
PDF file
ABAlexander A. Baranov
Alexander A. Baranov
LNLeyla S. Namazova-Baranova
Leyla S. Namazova-Baranova
NBNikolay I. Brico
Nikolay I. Brico
YLYurii V. Lobzin
Yurii V. Lobzin
RКRoman S. Коzlov
Roman S. Коzlov
СХС. Р. Харит
С. Р. Харит
Pneumococcal infection remains one of the leading reasons for infant mortality from vaccine-preventable infections. Today vaccination is the most effective way to prevent diseases caused by antibiotic-resistant pneumococci. In the article, authors present current approaches to vaccinal prevention of pneumococcal diseases. The plan of action for carrying out active immunoprophylaxis of pneumococcal infection is explained in detail for both healthy children and patients from risk groups for severe pneumococcal diseases development. The published work is based on key points of the guidelines of the Ministry of Health of the Russian Federation on vaccinal prevention of pneumococcal infection (developed and approved by the professional association of pediatricians «The Union of Pediatricians of Russia»).

1 August 2017 in Pediatric pharmacology
Verified
Journal Article
Open access
PDF file
ABAlexander A. Baranov
Alexander A. Baranov
YLYuriy V. Lobzin
Yuriy V. Lobzin
LNLeyla S. Namazova-Baranova
Leyla S. Namazova-Baranova
VTVladimir K. Tatochenko
Vladimir K. Tatochenko
AUAlexander N. Uskov
Alexander N. Uskov
EPElena A. Promyslova
Elena A. Promyslova
The article is devoted to acute respiratory viral infections (ARVI) in children. ARVI take one of the leading places in a childhood morbidity structure. The article provides an overview of the clinical guidelines developed and approved by the professional association «Union of Pediatricians of Russia» for acute respiratory infections in children. These guidelines summarize the experience of the leading world and domestic specialists, contain scientific and practical data that correspond to the most relevant trends in the management of children with this pathology. The authors present modern information on the etiology, pathogenesis, classification, clinical findings and differential diagnosis of various nosological forms of acute respiratory tract infections in the pediatric population. The general (strategic) principles of drug-free and drug treatment are discussed in detail.

1 January 2017 in Current Pediatrics
Verified
Journal Article
Open access
PDF file
AБArray А. Баранов
Array А. Баранов
LNLeyla S. Namazova-Baranova
Leyla S. Namazova-Baranova
VTV. K. Tatochenko
V. K. Tatochenko
EVE. A. Vishneva
E. A. Vishneva
MFMarina Vladislavovna Fedoseenko
Marina Vladislavovna Fedoseenko
AБArray Д. Белоцерковцева
Array Д. Белоцерковцева
Вакцинопрофилактика заболеваний, вызванных вирусом папилломы человека: позиции доказательной медицины. Обзор клинических рекомендаций